Article info
PDFORIGINAL ARTICLE
Phase II study of irinotecan plus doxorubicin for early recurrent or platinum-refractory ovarian cancer: interim analysis
- Address correspondence and reprint requests to: Sadako Nishimura, MD, PhD, Department of Obstetrics and Gynecology, Osaka City General Hospital, 2-13-22, Miyakojimahondori, Miyakojima-ku, Osaka 534-0021, Japan. Email: sadakon{at}msic.med.osaka-cu.ac.jp
Citation
Phase II study of irinotecan plus doxorubicin for early recurrent or platinum-refractory ovarian cancer: interim analysis
Publication history
- First published January 1, 2007.
Online issue publication
March 05, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2007 Blackwell Publishing Ltd.